Patents by Inventor JEAN-PIERRE ROUTY

JEAN-PIERRE ROUTY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11707508
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: July 25, 2023
    Assignee: ARES TRADING S.A.
    Inventors: Alena Zalutskaya, John Gourley, Nicolas Chomont, Jean-Pierre Routy, Steven Deeks
  • Publication number: 20200061159
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Application
    Filed: November 11, 2019
    Publication date: February 27, 2020
    Inventors: ALENA ZALUTSKAYA, JOHN GOURLEY, NICOLAS CHOMONT, JEAN-PIERRE ROUTY, STEVEN DEEKS
  • Publication number: 20180193425
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Application
    Filed: January 11, 2018
    Publication date: July 12, 2018
    Inventors: ALENA ZALUTSKAYA, JOHN GOURLEY, NICOLAS CHOMONT, JEAN-PIERRE ROUTY, STEVEN DEEKS